The Research Ethics Board (REB) adopts a proportionate approach to ethics review, in that the level of REB review is determined by the level of risk presented by the research. There are two levels of REB review possible for brand new studies: Full Board review and Delegated review (expedited). For example, clinical trials fall under Full Board review, whereas minimal risk studies fall under Delegated review. However, at the discretion of the REB office and REB Chair, your study may be assigned to Full Board review.
The ROHCG REB has instituted a 2-step application and review process. All applications, whether full board or delegated, must be submitted for preliminary review prior to applying for REB review. Once your project has received preliminary review approval, you may submit your study for REB review.
All submissions (chart review, observational studies, interventional and clinical trials), regardless of review level, must be submitted using the REB System: https://theroyal.forms.ethicalreviewmanager.com/
For guidance on how to use the REB System, please review the System Guide for REB Applicants.
If you will be conducting a study at both The Royal REB and OHSN-REB (e.g., cross-appointed investigator and/or study activity), please submit your study to the following website to determine which REB will review your application: https://omc.ohri.ca/REB-Royal/